These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

742 related items for PubMed ID: 30799536

  • 1. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y, Xi H, Xie T, Qiu Z, Wang X, Wei B, Chen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):143-148. PubMed ID: 30799536
    [Abstract] [Full Text] [Related]

  • 2. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S, Yuan Y, Hu H, Li R, Liu K, Zhang W, Yang K, Yang Y, Bai D, Chen X, Zhou Z, Chen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):132-142. PubMed ID: 30799535
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD, Luo ZL, Fu MY, Tian D, Zhang L, Zhang KP.
    Zhonghua Zhong Liu Za Zhi; 2014 Dec 23; 36(12):916-21. PubMed ID: 25623766
    [Abstract] [Full Text] [Related]

  • 4. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D, Cao S, Tan X, Liu S, Liu X, Niu Z, Chen D, Wang D, Zhang J, Lv L, Li Y, Jiang H, Guo D, Li Y, Li Z, Zhou Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):156-163. PubMed ID: 30799538
    [Abstract] [Full Text] [Related]

  • 5. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
    Liu K, Feng F, Chen XZ, Zhou XY, Zhang JY, Chen XL, Zhang WH, Yang K, Zhang B, Zhang HW, Zhou ZG, Hu JK.
    Gastric Cancer; 2019 May 25; 22(3):506-517. PubMed ID: 30390154
    [Abstract] [Full Text] [Related]

  • 6. Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us?
    Zanoni A, Verlato G, Baiocchi GL, Casella F, Cossu A, d'Ignazio A, De Pascale S, Giacopuzzi S.
    Updates Surg; 2018 Jun 25; 70(2):241-249. PubMed ID: 29808375
    [Abstract] [Full Text] [Related]

  • 7. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y, Wang Q, Wang J, Qiao XY, Zhang J, Lin YC, Li Y, Fan LQ, Yang PG, Zhao Q.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb 25; 24(2):128-137. PubMed ID: 33508918
    [Abstract] [Full Text] [Related]

  • 8. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB, Lin MQ, Li P, Xie JW, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Zheng CH, Huang CM.
    Eur J Surg Oncol; 2017 Dec 25; 43(12):2333-2340. PubMed ID: 28928013
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
    Karstens KF, Ghadban T, Sawez S, Konczalla L, Woestemeier A, Bachmann K, Uzunoglu FG, Tachezy M, Vettorazzi E, Izbicki JR, Reeh M.
    Eur J Surg Oncol; 2020 Apr 25; 46(4 Pt A):638-643. PubMed ID: 31879051
    [Abstract] [Full Text] [Related]

  • 10. Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems.
    Kim HI, Cheong JH, Song KJ, An JY, Hyung WJ, Noh SH, Kim CB.
    Ann Surg Oncol; 2013 Aug 25; 20(8):2713-20. PubMed ID: 23456315
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL, Zhao LY, Zhang WH, Liu K, Pang HY, Chen XL, Chen XZ, Yang K, Hu JK.
    Langenbecks Arch Surg; 2022 May 25; 407(3):985-998. PubMed ID: 34792614
    [Abstract] [Full Text] [Related]

  • 12. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C, Zhu HT, Xu ZY, Yu JF, Du YA, Huang L, Yu PF, Wang LJ, Cheng XD.
    J Int Med Res; 2019 Jan 25; 47(1):398-410. PubMed ID: 30296865
    [Abstract] [Full Text] [Related]

  • 13. Can Clinical Stage in the 8th Edition of the Union for International Cancer Control TNM Classification Stratify the Prognosis of Patients Undergoing Curative Surgery for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction?
    Watanabe H, Hasegawa S, Kumazu Y, Hashimoto I, Komori K, Suematsu H, Kano K, Fujikawa H, Aoyama T, Yamada T, Yukawa N, Yoshikawa T, Rino Y, Saito A, Ogata T, Oshima T.
    In Vivo; 2023 Jan 25; 37(4):1790-1796. PubMed ID: 37369497
    [Abstract] [Full Text] [Related]

  • 14. A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal versus Gastric Staging System for Gastroesophageal Junction Cancer in a Western Population.
    Adeshuko FA, Squires MH, Poultsides G, Pawlik TM, Weber SM, Schmidt C, Votanopoulos K, Fields RC, Maithel SK, Cardona K.
    Am Surg; 2017 Jan 01; 83(1):82-89. PubMed ID: 28234131
    [Abstract] [Full Text] [Related]

  • 15. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D.
    World J Gastroenterol; 2018 Apr 07; 24(13):1429-1439. PubMed ID: 29632424
    [Abstract] [Full Text] [Related]

  • 16. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
    Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL.
    Ann Thorac Surg; 2019 Sep 07; 108(3):845-851. PubMed ID: 31102632
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T.
    Ann Surg Oncol; 2012 Feb 07; 19(2):677-83. PubMed ID: 21822549
    [Abstract] [Full Text] [Related]

  • 18. [CT in differentiation of cT3 and cT4a Siewert type II esophagogastric junction adenocarcinoma: A comparison study based on UICC/AJCC 8th edition and IGCA 4th edition].
    Fu J, Tang L, Li Z, Li X, Zhang Y, Gao S, Sun Y, Ji J.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep 25; 21(9):1013-1018. PubMed ID: 30269321
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 20. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S, Kurokawa Y, Takeuchi H, Kishi K, Ito Y, Ohi M, Matsuda T, Hamakawa T, Hasegawa S, Yoshikawa T, Hiki N.
    Eur J Surg Oncol; 2015 Oct 25; 41(10):1348-53. PubMed ID: 26087995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.